Illumina, Inc. (ILMN)
NASDAQ: ILMN · Real-Time Price · USD
79.09
-1.21 (-1.51%)
May 14, 2025, 9:51 AM - Market open

Illumina Market Cap

Illumina has a market cap or net worth of $12.52 billion as of May 14, 2025. Its market cap has decreased by -34.91% in one year.

Market Cap
12.52B
Enterprise Value
14.08B
1-Year Change
-34.91%
Ranking
Category
Stock Price
$79.09

Market Cap Chart

Since July 28, 2000, Illumina's market cap has increased from $1.24B to $12.52B, an increase of 913.35%. That is a compound annual growth rate of 9.79%.

History

DateMarket Cap% Change
May 12, 202512.91B-39.07%
Dec 31, 202421.19B-4.15%
Dec 29, 202322.11B-30.48%
Dec 30, 202231.81B-46.51%
Dec 31, 202159.46B10.08%
Dec 31, 202054.02B10.77%
Dec 31, 201948.77B10.61%
Dec 31, 201844.09B38.21%
Dec 29, 201731.90B69.60%
Dec 30, 201618.81B-33.07%
Dec 31, 201528.10B7.21%
Dec 31, 201426.21B87.51%
Dec 31, 201313.98B104.45%
Dec 31, 20126.84B84.71%
Dec 30, 20113.70B-53.27%
Dec 31, 20107.92B106.38%
Dec 31, 20093.84B19.06%
Dec 31, 20083.22B-0.56%
Dec 31, 20073.24B77.31%
Dec 29, 20061.83B215.10%
Dec 30, 2005580.20M60.72%
Dec 31, 2004361.00M55.87%
Dec 31, 2003231.60M111.51%
Dec 31, 2002109.50M-71.10%
Dec 31, 2001378.90M-26.13%
View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 671.25B
Johnson & Johnson 371.71B
UnitedHealth Group 345.78B
AbbVie 335.72B
Novo Nordisk 297.79B
Abbott Laboratories 232.48B
Novartis AG 214.71B
AstraZeneca 211.14B
Market Cap Rankings